Icon Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,400
| Closed | -$2.46M | – | 189 |
|
|
2020
Q3 | $2.46M | Hold |
4,400
| – | – | 0.48% | 76 |
|
|
2020
Q2 | $2.74M | Buy |
4,400
+1,400
| +47% | +$873K | 0.54% | 59 |
|
|
2020
Q1 | $1.47M | Hold |
3,000
| – | – | 0.32% | 109 |
|
|
2019
Q4 | $1.13M | Hold |
3,000
| – | – | 0.16% | 179 |
|
|
2019
Q3 | $832K | Hold |
3,000
| – | – | 0.12% | 212 |
|
|
2019
Q2 | $939K | Hold |
3,000
| – | – | 0.09% | 206 |
|
|
2019
Q1 | $1.23M | Hold |
3,000
| – | – | 0.12% | 172 |
|
|
2018
Q4 | $1.12M | Hold |
3,000
| – | – | 0.12% | 168 |
|
|
2018
Q3 | $1.21M | Hold |
3,000
| – | – | 0.1% | 192 |
|
|
2018
Q2 | $1.04M | Hold |
3,000
| – | – | 0.08% | 208 |
|
|
2018
Q1 | $1.03M | Hold |
3,000
| – | – | 0.08% | 212 |
|
|
2017
Q4 | $1.13M | Hold |
3,000
| – | – | 0.08% | 217 |
|
|
2017
Q3 | $1.34M | Buy |
+3,000
| New | +$1.34M | 0.09% | 233 |
|
|
2016
Q4 | – | Sell |
-2,200
| Closed | -$884K | – | 443 |
|
|
2016
Q3 | $884K | Sell |
2,200
-6,400
| -74% | -$2.57M | 0.06% | 310 |
|
|
2016
Q2 | $3M | Buy |
8,600
+6,600
| +330% | +$2.3M | 0.2% | 156 |
|
|
2016
Q1 | $721K | Buy |
+2,000
| New | +$721K | 0.05% | 255 |
|
|
2014
Q4 | – | Sell |
-11,900
| Closed | -$4.29M | – | 346 |
|
|
2014
Q3 | $4.29M | Buy |
11,900
+5,300
| +80% | +$1.91M | 0.25% | 108 |
|
|
2014
Q2 | $1.86M | Buy |
+6,600
| New | +$1.86M | 0.12% | 150 |
|